Akebia Therapeutics, Inc.
AKBAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Akebia Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 14 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| GROUP ONE TRADING LLC | 2026-03-31 | 97,687 | $136K | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 148,092 | $206K | SEC filing |
| Fiduciary Trust Co | 2026-03-31 | 100,000 | $139K | SEC filing |
| Virtu Financial LLC | 2026-03-31 | 24,511 | Not shown | SEC filing |
| State of Alaska, Department of Revenue | 2026-03-31 | 146,078 | Not shown | SEC filing |
| VICTORY CAPITAL MANAGEMENT INC | 2026-03-31 | 129,170 | $180K | SEC filing |
| Round Rock Advisors LLC | 2026-03-31 | 166,089 | $231K | SEC filing |
| Clear Harbor Asset Management, LLC | 2026-03-31 | 10,000 | $13.9K | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 1,995 | $2.67K | SEC filing |
| VIRTUS ADVISERS, LLC | 2026-03-31 | 308,000 | $428K | SEC filing |
| Graham Capital Management, L.P. | 2026-03-31 | 248,352 | $345K | SEC filing |
| Voleon Capital Management LP | 2026-03-31 | 675,656 | $939K | SEC filing |
| Hughes Financial Services, LLC | 2026-03-31 | 15 | $21 | SEC filing |
| VOYA INVESTMENT MANAGEMENT LLC | 2026-03-31 | 44,403 | $61.7K | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 7,632 | $10.6K | SEC filing |
| Eaton Financial Holdings Company, LLC | 2026-03-31 | 11,800 | $16.4K | SEC filing |
| TD Waterhouse Canada Inc. | 2026-03-31 | 327 | $461 | SEC filing |
| Quantbot Technologies LP | 2026-03-31 | 12,095 | $16.8K | SEC filing |
| ROYCE & ASSOCIATES LP | 2026-03-31 | 28,373 | $39.4K | SEC filing |
| Man Group plc | 2026-03-31 | 257,854 | $358K | SEC filing |
- Each value is checked against Akebia Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Akebia Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Akebia Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-02 · Butler John P.: Larger than all 86 other insider sales of Common Stock on file. SEC filing
- 2026-02-02 · Butler John P.: Larger than 84 of the 86 other insider sales of Common Stock on file. SEC filing
- 2026-02-02 · Butler John P.: Larger than 82 of the 86 other insider sales of Common Stock on file. SEC filing
- 2025-02-03 · Butler John P.: Larger than 85 of the 86 other insider sales of Common Stock on file. SEC filing
- 2025-02-03 · Grund Nicholas: Larger than 78 of the 86 other insider sales of Common Stock on file. SEC filing
- 2023-05-25 · Dahan Michel: Larger than 83 of the 86 other insider sales of Common Stock on file. SEC filing
- 2023-05-25 · Hadas Nicole R.: Larger than 79 of the 86 other insider sales of Common Stock on file. SEC filing
- 2023-05-16 · Spellman David A: Larger than 80 of the 86 other insider sales of Common Stock on file. SEC filing
- 2023-05-16 · Burke Steven Keith: Larger than 80 of the 86 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-04 | Butler John P. · CEO and President | Common Stock | P — Open market or private purchase | +69,270 | 1.25 | SEC filing |
| 2026-02-02 | Malabre Richard C · SVP, Chief Accounting Officer | Common Stock | S — Open market or private sale | −36,142 | 1.39 | SEC filing |
| 2026-02-02 | Rucci Carolyn M. · SVP, Chief Legal Officer | Common Stock | S — Open market or private sale | −25,382 | 1.39 | SEC filing |
| 2026-02-02 | Butler John P. · CEO and President | Common Stock | S — Open market or private sale | −83,689 | 1.39 | SEC filing |
| 2026-02-02 | Grund Nicholas · Chief Commercial Officer | Common Stock | S — Open market or private sale | −31,244 | 1.39 | SEC filing |
| 2026-02-02 | Butler John P. · CEO and President | Common Stock | S — Open market or private sale | −96,065 | 1.39 | SEC filing |
| 2026-02-02 | Grund Nicholas · Chief Commercial Officer | Common Stock | S — Open market or private sale | −53,585 | 1.39 | SEC filing |
| 2026-02-02 | Butler John P. · CEO and President | Common Stock | S — Open market or private sale | −114,891 | 1.39 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-17 | Smith Cynthia · Director | Common Stock | A — Grant, award, or other acquisition | +35,700 | SEC filing |
| 2026-06-17 | ROGERS MICHAEL W · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +53,600 | SEC filing |
| 2026-06-17 | ZUMWALT LEANNE M · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +53,600 | SEC filing |
| 2026-06-17 | FRIESON RON · Director | Common Stock | A — Grant, award, or other acquisition | +35,700 | SEC filing |
| 2026-06-17 | ADAMS ADRIAN · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +53,600 | SEC filing |
| 2026-06-17 | ADAMS ADRIAN · Director | Common Stock | A — Grant, award, or other acquisition | +35,700 | SEC filing |
| 2026-06-17 | Wolf Myles · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +53,600 | SEC filing |
| 2026-06-17 | Wolf Myles · Director | Common Stock | A — Grant, award, or other acquisition | +35,700 | SEC filing |
Showing 8 of 14 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2018-12-12 (amended) | Butler John P. · CEO and President | Common Stock | J — Other acquisition or disposition | +1,248 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.